These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6800819)

  • 21. Long-term captopril treatment in moderate to severe hypertension.
    Santucci A; Aguglia F; De Mattia G; Ficara C; Balsano F
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):77S-79S. PubMed ID: 6753908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    Clin Pharmacol Ther; 1984 Oct; 36(4):456-63. PubMed ID: 6206977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluctuations in the plasma angiotensin I converting enzyme activity during long-term treatment with captopril.
    Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
    Acta Cardiol; 1982; 37(1):1-9. PubMed ID: 6282024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
    Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F
    J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of various doses of captopril on plasma aldosterone concentrations in patients with essential hypertension.
    Izumi Y; Honda M; Hatano M
    Endocrinol Jpn; 1982 Dec; 29(6):717-23. PubMed ID: 6763896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive and hormonal effects of single oral doses of captopril and nifedipine in essential hypertension.
    Soto ME; Thibonnier M; Sire O; Menard J; Corvol P; Milliez P
    Eur J Clin Pharmacol; 1981; 20(3):157-61. PubMed ID: 7026255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between blood pressure and blood levels of angiotensin I converting enzyme inhibitor (SQ 14,225).
    Honda M; Izumi Y; Kawahara Y; Hatano M
    Jpn Circ J; 1981 Sep; 45(9):1025-9. PubMed ID: 7029028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic and humoral interactions between captopril and nifedipine.
    Stornello M; Di Rao G; Iachello M; Pisani R; Scapellato L; Pedrinelli R; Salvetti A
    Hypertension; 1983; 5(5 Pt 2):III154-6. PubMed ID: 6354932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Captopril before and after spironolactone therapy in primary aldosteronism. Pathogenetic and therapeutical aspects.
    Stimpel M; Vetter W; Groth H; Greminger P; Vetter H
    Klin Wochenschr; 1985 Apr; 63(8):361-3. PubMed ID: 3889485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Captopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. A controlled long-term study with reference to initial plasma renin activity.
    Karlberg BE; Asplund J; Nilsson OR; Wettre S; Ohman KP
    Acta Med Scand; 1981; 209(4):245-52. PubMed ID: 7015795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension.
    Vandenburg MJ; Holly JM; Goodwin FJ; Sharman VL; Marsh FP
    Eur J Clin Pharmacol; 1983; 25(6):721-8. PubMed ID: 6319152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses.
    Baer L; Radichevich I; Williams GS
    J Cardiovasc Pharmacol; 1980; 2 Suppl 2():S206-16. PubMed ID: 6156357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of captopril on catecholamines, renin activity, angiotensin II and aldosterone in plasma during physical exercise in hypertensive patients.
    Manhem P; Bramnert M; Hulthén UL; Hökfelt B
    Eur J Clin Invest; 1981 Oct; 11(5):389-95. PubMed ID: 6800810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive patients on hemodialysis.
    Kaneda H; Murata T; Matsumoto J; Maeta T; Shitomi K; Haruyama T
    Tohoku J Exp Med; 1982 May; 137(1):21-31. PubMed ID: 7048628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension.
    Aldigier JC; Plouin PF; Guyene TT; Thibonnier M; Corvol P; Menard J
    Am J Cardiol; 1982 Apr; 49(6):1447-52. PubMed ID: 7041584
    [No Abstract]   [Full Text] [Related]  

  • 37. [Captopril in the treatment of essential hypertension (author's transl)].
    Lederle RM; Klaus D; Braun B
    Dtsch Med Wochenschr; 1980 Sep; 105(38):1307-12. PubMed ID: 6257467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.
    Atkinson AB; Cumming AM; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1982 Jun; 13(6):855-8. PubMed ID: 7046776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive effect of the oral angiotensin I-converting enzyme inhibitor in long-term treatment of hypertensive patients.
    Mizuno K; Gotoh M; Matsui J; Fukuchi S
    Jpn Heart J; 1981 Nov; 22(6):903-13. PubMed ID: 7040724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase in plasma aldosterone during prolonged captopril treatment.
    Lijnen P; Staessen J; Fagard R; Amery A
    Am J Cardiol; 1982 Apr; 49(6):1561-3. PubMed ID: 7041598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.